|
Market Closed -
London S.E.
23:45:34 03/11/2025 HKT
|
After hours 23:25:00 | |||
| 31.92 SEK | -32.03% |
|
0.0620 | -99.81% |
| 10-05 | 23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 10-05 | Immunovia no longer has any public short sellers | FW |
Company Valuation: Immunovia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,697 | 595.2 | 92.66 | 152.7 | 43.39 | - | - |
| Change | - | -64.93% | - | 64.79% | -71.59% | - | - |
| Enterprise Value (EV) 1 | 1,443 | 526.7 | 92.66 | 76.09 | 8.387 | 13.39 | -11.61 |
| Change | - | -63.5% | - | -17.88% | -88.98% | 59.62% | -186.75% |
| P/E | -0.11x | -0.04x | -0.01x | -0.54x | -0.71x | -1.78x | -3.56x |
| PBR | 0.04x | 0.02x | - | - | - | - | - |
| PEG | - | -0.01x | - | 0x | 0x | 0x | 0.1x |
| Capitalization / Revenue | 1,775x | 494x | - | 203x | 13.6x | 2.51x | 0.79x |
| EV / Revenue | 1,510x | 437x | - | 101x | 2.62x | 0.77x | -0.21x |
| EV / EBITDA | -9.78x | -3.17x | - | -0.97x | -0.1x | -0.18x | 0.28x |
| EV / EBIT | -8.66x | -2.76x | - | -0.95x | -0.1x | -0.18x | 0.26x |
| EV / FCF | -9.27x | -2.97x | - | -0.91x | -0.1x | -0.17x | 0.23x |
| FCF Yield | -10.8% | -33.6% | - | -110% | -1,037% | -598% | 431% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -689 | -743 | -93 | -0.42 | -0.1 | -0.04 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.956 | 1.204 | - | 0.752 | 3.2 | 17.3 | 55 |
| EBITDA 1 | -147.6 | -166.2 | - | -78.06 | -85 | -74 | -42 |
| EBIT 1 | -166.6 | -191.2 | - | -80.38 | -88 | -76 | -45 |
| Net income 1 | -156 | -168.1 | -76.54 | -145.9 | -87 | -76 | -45 |
| Net Debt 1 | -254.1 | -68.47 | - | -76.6 | -35 | -30 | -55 |
| Reference price 2 | 75.0000 | 26.3000 | 0.5460 | 0.2270 | 0.0711 | 0.0711 | 0.0711 |
| Nbr of stocks (in thousands) | 22,632 | 22,632 | 169,711 | 672,667 | 672,667 | - | - |
| Announcement Date | 17/2/22 | 23/2/23 | 25/2/25 | 24/2/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.63x | 5.87x | 22.5x | 0.27% | 250B | |
| 37.48x | 6.69x | 21.17x | 0.67% | 156B | |
| 44.05x | 11.66x | 25.72x | -.--% | 144B | |
| 16.03x | 3.31x | 10.8x | -.--% | 61.45B | |
| 34.47x | 6.9x | 21.87x | -.--% | 50.28B | |
| 18.42x | 2.25x | 11.43x | 2.73% | 46.73B | |
| 33.36x | 6.6x | 22.41x | 0.6% | 48.29B | |
| 43.4x | 10.52x | 23.2x | -.--% | 45.89B | |
| 77.05x | 7.33x | 22.33x | -.--% | 43.24B | |
| Average | 37.54x | 6.79x | 20.16x | 0.48% | 93.91B | |
| Weighted average by Cap. | 36.78x | 7.05x | 21.33x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
- Valuation Immunovia AB
Select your edition
All financial news and data tailored to specific country editions
